ArticleAge and ageing2025
Effectiveness of a fall and fracture prevention pathway on hip fracture risk, need of permanent care and mortality: a controlled before-and-after study.
Article in Age and ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Emergency Department Encounters Preceding Hip Fracture in Older Adults: A Window for Future Risk Identification.Journal of the American College of Emergency Physicians open · 2026Article
- Observational
- Engineered bone-targetingMaterials today. Bio · 2026Article
- An orthogeriatric quality improvement initiative from the European Academy for Medicine of Ageing (EAMA): enhancing osteoporosis treatment and fall prevention.European geriatric medicine · 2026Article
- Rising burden of fall-induced hip fractures in China: accelerating male-specific trends and persistent gender disparities from Global Burden of Disease 2021.Acta orthopaedica et traumatologica turcica · 2026Article
- Disease Burden Attributable to Hip Fractures in Asian Women.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe high rates of hip fracture in Oslo inspired a new fall prevention pathway based on well-established fall prevention strategies, but specifically focusing on care coordination, osteoporosis treatment and targeting high-risk patients.
objectiveTo evaluate the effectiveness of the fall prevention pathway.
methodsWe performed a controlled before-and-after study in the home-dwelling population aged 65+ years in Oslo, Norway. The intervention consisted of identifying older adults with a fall-related injury, offering them risk assessment and tailored interventions. Using registry data, we compared registered fallers in the two intervention boroughs with the remaining 13 boroughs as controls, with registered fall injuries as time-dependent exposure in Cox regression. Hazard ratios (HRs) for later hip fracture, long-term care and all-cause mortality were estimated, adjusting for the pre-intervention period.
resultsThe risk of hip fracture for the Oslo population aged 65+ years declined by 23% from 2012-19. HR for hip fracture amongst registered fallers in the intervention boroughs compared to the controls was 0.95 (95% CI 0.64-1.41). The difference was significant in men only [HR 0.45 (95% CI 0.21-0.95)]. The risk of admittance to long-term care was reduced [HR 0.76 (95% CI 0.62-0.93)]. No significant difference was seen in mortality.
conclusionsOverall, the risk of later hip fracture was not significantly reduced in all registered fallers in the intervention boroughs, only in men. There was a significant decline in risk of admission to nursing homes in the intervention boroughs. These results suggest that the prevention pathway might have slowed down functional decline in the older Oslo population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.